Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers
Dexcom
26 episodes
3 weeks ago
Enhancing diabetes care with real-time continuous glucose monitoring (CGM) is the focus of Real-Time Real Talk, the go-to podcast for healthcare professionals in the U.S. Whether you're an endocrinologist, primary care physician, diabetes educator, or pharmacist, this show provides expert insights and real-world applications to help you optimize patient outcomes with CGM technology. Each month, Real-Time Real Talk brings you in-depth conversations with leading clinicians, researchers, and industry experts, diving into: How to integrate real-time CGM into your practice – Learn best practices for onboarding patients and interpreting CGM data The latest clinical evidence – Explore groundbreaking studies on real-time CGM and its impact on glucose tracking Real-world success stories – Hear firsthand experiences from healthcare providers and patients using Dexcom G7 and Stelo to manage type 1 diabetes, type 2 diabetes and prediabetes. Episode topics have included: Type 2 Diabetes Management Through Glucose Tracking: How CGM Improves Patient Outcomes with Dr. Thomas Grace and Dr. William Polonsky Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes with Emily Cornelius, Registered Dietitian Empowering Diabetes Care: Revolutionizing Hospital Discharge Planning with CGM Technology with David Tulle Real-Time Real Talk is your trusted source for staying up to date on CGM advancements. Hosted by Cher Pastore (MS, RD, CDCES, BC-ADM), she is a registered dietitian and certified diabetes care and education specialist, holding a Master of Science in Nutrition from New York University and a Bachelor of Arts in Psychology from University of Massachusetts Boston. She is also a Director of clinical education at Dexcom. Prior to joining Dexcom, Cher was in clinical practice for more than 10 years, specializing in diabetes technology. While in practice, she developed a love of using CGM as a tool in diabetes care. Cher has been featured in such publications as People, D-Life, Everyday Health, and Diabetes Daily, and has appeared in broadcasts on SiriusXM, Extra TV, Channel 5, Channel 7 News. Now, she's excited to share her expertise on a medical podcast. Dexcom is a leader in real-time CGM technology, empowering patients and healthcare providers with accurate, real-time glucose insights. Dexcom has won more than 20 awards over the last 2 years including: 2025 CES Innovation Award Honoree 2023 Healthcare Marketing Impact Award - Film/TV/Video Campaign of the Year ◦ Dexcom Super Bowl Commercial with Nick Jonas and everyday ‘warriors’ 2024 German Design Award – Dexcom G7 CGM System Learn more at dexcom.com. Want to get involved with the show? You can reach us at Cher.pastore@dexcom.com to: Bring Dexcom to your event Be a guest on the show Ask Cher a question If you like Diabetes Core Update, Juicebox Podcast: Type 1 Diabetes, The Huddle: Conversations with the Diabetes Care Team, you’ll enjoy Real-Time Real Talk.
All content for Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers is the property of Dexcom and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Enhancing diabetes care with real-time continuous glucose monitoring (CGM) is the focus of Real-Time Real Talk, the go-to podcast for healthcare professionals in the U.S. Whether you're an endocrinologist, primary care physician, diabetes educator, or pharmacist, this show provides expert insights and real-world applications to help you optimize patient outcomes with CGM technology. Each month, Real-Time Real Talk brings you in-depth conversations with leading clinicians, researchers, and industry experts, diving into: How to integrate real-time CGM into your practice – Learn best practices for onboarding patients and interpreting CGM data The latest clinical evidence – Explore groundbreaking studies on real-time CGM and its impact on glucose tracking Real-world success stories – Hear firsthand experiences from healthcare providers and patients using Dexcom G7 and Stelo to manage type 1 diabetes, type 2 diabetes and prediabetes. Episode topics have included: Type 2 Diabetes Management Through Glucose Tracking: How CGM Improves Patient Outcomes with Dr. Thomas Grace and Dr. William Polonsky Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes with Emily Cornelius, Registered Dietitian Empowering Diabetes Care: Revolutionizing Hospital Discharge Planning with CGM Technology with David Tulle Real-Time Real Talk is your trusted source for staying up to date on CGM advancements. Hosted by Cher Pastore (MS, RD, CDCES, BC-ADM), she is a registered dietitian and certified diabetes care and education specialist, holding a Master of Science in Nutrition from New York University and a Bachelor of Arts in Psychology from University of Massachusetts Boston. She is also a Director of clinical education at Dexcom. Prior to joining Dexcom, Cher was in clinical practice for more than 10 years, specializing in diabetes technology. While in practice, she developed a love of using CGM as a tool in diabetes care. Cher has been featured in such publications as People, D-Life, Everyday Health, and Diabetes Daily, and has appeared in broadcasts on SiriusXM, Extra TV, Channel 5, Channel 7 News. Now, she's excited to share her expertise on a medical podcast. Dexcom is a leader in real-time CGM technology, empowering patients and healthcare providers with accurate, real-time glucose insights. Dexcom has won more than 20 awards over the last 2 years including: 2025 CES Innovation Award Honoree 2023 Healthcare Marketing Impact Award - Film/TV/Video Campaign of the Year ◦ Dexcom Super Bowl Commercial with Nick Jonas and everyday ‘warriors’ 2024 German Design Award – Dexcom G7 CGM System Learn more at dexcom.com. Want to get involved with the show? You can reach us at Cher.pastore@dexcom.com to: Bring Dexcom to your event Be a guest on the show Ask Cher a question If you like Diabetes Core Update, Juicebox Podcast: Type 1 Diabetes, The Huddle: Conversations with the Diabetes Care Team, you’ll enjoy Real-Time Real Talk.
Unleashing the Power of Partnerships: Tandem Control IQ & Dexcom G7
Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers
23 minutes
1 year ago
Unleashing the Power of Partnerships: Tandem Control IQ & Dexcom G7
In this episode of Dexcom’s Real Time Real Talk, we’re speaking to Tandem’s Medical Director, Jordan Pinkster. Jordan is a pediatric endocrinologist by training, but has been involved in clinical trials and the development of automated insulin delivery products for many years. Our second guest is Kristy Castillo, the clinical solutions manager at Tandem who is also a nurse, diabetes educator and lives with type one diabetes herself. We’ll discuss Tandem products including the sleek new number 1 one rated AID system, the t:slim X2 insulin pump, we’ll talk about how it integrates with the Dexcom G6 and G7 and Kristy also shares her first-hand experience of using it. Finally we’ll discuss the advantages of connecting your AID system to your smartphone where possible, not just for those with diabetes but also for health care professionals.Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G7 User Guide. For product-related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility. The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy.The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older.Dexcom’s partners are working to integrate insulin pumps, insulin pens, and digital health apps with Dexcom G7.Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.A separate Follow app and internet connection are required to follow CGM users’ glucose readings and trends. CGM users should always confirm glucose readings on the Dexcom G7 app or receiver before making treatment decisions.Dr Jordan Pinsker and Kristy Castillo are employees of Tandem Diabetes Care. About Tandem Diabetes Care: https://www.tandemdiabetes.com/en-gb/homeWarning: Do not use the Dexcom G7 CGM System or the Dexcom G6 System if you are on dialysis. The performance of these CGM systems has not been evaluated in this population and sensor readings may be inaccurate.Brief Safety StatementBRIEF SAFETY STATEMENT: Failure to use the Dexcom G7 Continuous Glucose Monitoring System (G7) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose0 or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G7 do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.Dexcom Clarity Safety InformationThe web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional. Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries.Dexcom Provider website: https://provider.dexcom.com/Tandem Control IQ Clinical Evidence: https://www.tandemdiabetes.com/en-gb/homeReferences:1. Breton MD, Kovatchev BP. One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology. Diabetes Technol Ther. 2021 Sep;23(9):601-608. doi: 10.1089/dia.2021.0097. Epub 2021 Apr 21. PMID: 33784196; PMCID: PMC8501470.2. Roy W. Beck, Lauren G. Kanapka, Marc D. Breton, Sue A. Brown, R. Paul Wadwa, Bruce A. Buckingham, Craig Kollman, and Boris Kovatchev.A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.Diabetes Technology & Therapeutics.May 2023.329-342.http://doi.org/10.1089/dia.2022.05583. S.A. Brown, B.P. Kovatchev, D. Raghinaru, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes N Engl J Med 2019;381:1707-17. DOI: 10.1056/NEJMoa19078634. Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer M, Ruedy KJ, Jost E, Carria L, Emory E, Hsu LJ, Oliveri M, Kollman CC, Dokken BB, Weinzimer SA, DeBoer MD, Buckingham BA, Cherñavvsky D, Wadwa RP; iDCL Trial Research Group. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med. 2020 Aug 27;383(9):836-845. doi: 10.1056/NEJMoa2004736. PMID: 32846062; PMCID: PMC7920146.5. Marc D. Breton and Boris P. Kovatchev One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology, Diabetes Technology & Therapeutics 2021 23:9, 601-608 6. Boris P. Kovatchev, Harsimran Singh, Lars Mueller, Linda A. Gonder-Frederick; Biobehavioral Changes Following Transition to Automated Insulin Delivery: A Large Real-life Database Analysis. Diabetes Care 1 November 2022; 45 (11): 2636–2643. https://doi.org/10.2337/dc22-1217
Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers
Enhancing diabetes care with real-time continuous glucose monitoring (CGM) is the focus of Real-Time Real Talk, the go-to podcast for healthcare professionals in the U.S. Whether you're an endocrinologist, primary care physician, diabetes educator, or pharmacist, this show provides expert insights and real-world applications to help you optimize patient outcomes with CGM technology. Each month, Real-Time Real Talk brings you in-depth conversations with leading clinicians, researchers, and industry experts, diving into: How to integrate real-time CGM into your practice – Learn best practices for onboarding patients and interpreting CGM data The latest clinical evidence – Explore groundbreaking studies on real-time CGM and its impact on glucose tracking Real-world success stories – Hear firsthand experiences from healthcare providers and patients using Dexcom G7 and Stelo to manage type 1 diabetes, type 2 diabetes and prediabetes. Episode topics have included: Type 2 Diabetes Management Through Glucose Tracking: How CGM Improves Patient Outcomes with Dr. Thomas Grace and Dr. William Polonsky Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes with Emily Cornelius, Registered Dietitian Empowering Diabetes Care: Revolutionizing Hospital Discharge Planning with CGM Technology with David Tulle Real-Time Real Talk is your trusted source for staying up to date on CGM advancements. Hosted by Cher Pastore (MS, RD, CDCES, BC-ADM), she is a registered dietitian and certified diabetes care and education specialist, holding a Master of Science in Nutrition from New York University and a Bachelor of Arts in Psychology from University of Massachusetts Boston. She is also a Director of clinical education at Dexcom. Prior to joining Dexcom, Cher was in clinical practice for more than 10 years, specializing in diabetes technology. While in practice, she developed a love of using CGM as a tool in diabetes care. Cher has been featured in such publications as People, D-Life, Everyday Health, and Diabetes Daily, and has appeared in broadcasts on SiriusXM, Extra TV, Channel 5, Channel 7 News. Now, she's excited to share her expertise on a medical podcast. Dexcom is a leader in real-time CGM technology, empowering patients and healthcare providers with accurate, real-time glucose insights. Dexcom has won more than 20 awards over the last 2 years including: 2025 CES Innovation Award Honoree 2023 Healthcare Marketing Impact Award - Film/TV/Video Campaign of the Year ◦ Dexcom Super Bowl Commercial with Nick Jonas and everyday ‘warriors’ 2024 German Design Award – Dexcom G7 CGM System Learn more at dexcom.com. Want to get involved with the show? You can reach us at Cher.pastore@dexcom.com to: Bring Dexcom to your event Be a guest on the show Ask Cher a question If you like Diabetes Core Update, Juicebox Podcast: Type 1 Diabetes, The Huddle: Conversations with the Diabetes Care Team, you’ll enjoy Real-Time Real Talk.
